Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Receives $9.13 Consensus Target Price from Analysts

Shares of Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) have been given an average rating of “Moderate Buy” by the seven ratings firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $9.1250.

Several brokerages have weighed in on EVLV. Weiss Ratings reissued a “sell (d-)” rating on shares of Evolv Technologies in a report on Wednesday, October 8th. Zacks Research upgraded shares of Evolv Technologies from a “strong sell” rating to a “hold” rating in a research note on Friday, October 17th. Finally, Lake Street Capital upped their price target on shares of Evolv Technologies from $9.00 to $10.00 and gave the company a “buy” rating in a research note on Friday, November 14th.

Evolv Technologies Price Performance

NASDAQ EVLV opened at $7.13 on Friday. The firm’s fifty day simple moving average is $6.74 and its two-hundred day simple moving average is $7.14. The firm has a market capitalization of $1.25 billion, a P/E ratio of -19.27 and a beta of 1.85. The company has a current ratio of 1.27, a quick ratio of 1.20 and a debt-to-equity ratio of 0.28. Evolv Technologies has a 12-month low of $2.64 and a 12-month high of $8.91.

Evolv Technologies (NASDAQ:EVLV) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.01) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.06. Evolv Technologies had a negative return on equity of 55.11% and a negative net margin of 43.76%.The firm had revenue of $42.85 million during the quarter, compared to analysts’ expectations of $33.73 million. Analysts forecast that Evolv Technologies will post -0.27 EPS for the current fiscal year.

Insider Transactions at Evolv Technologies

In other news, Director Kevin M. Charlton acquired 15,000 shares of Evolv Technologies stock in a transaction dated Friday, November 21st. The stock was purchased at an average cost of $5.68 per share, for a total transaction of $85,200.00. Following the completion of the purchase, the director directly owned 44,081 shares in the company, valued at $250,380.08. This trade represents a 51.58% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Michael Ellenbogen sold 80,745 shares of the firm’s stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of $8.26, for a total transaction of $666,953.70. Following the transaction, the director directly owned 2,083,961 shares of the company’s stock, valued at approximately $17,213,517.86. This trade represents a 3.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have purchased 61,300 shares of company stock worth $363,326 and have sold 440,745 shares worth $3,618,954. Insiders own 11.30% of the company’s stock.

Institutional Trading of Evolv Technologies

Hedge funds have recently modified their holdings of the stock. Tudor Investment Corp ET AL grew its holdings in Evolv Technologies by 7.6% during the third quarter. Tudor Investment Corp ET AL now owns 1,055,016 shares of the company’s stock worth $7,965,000 after acquiring an additional 74,189 shares during the period. CIBC Bancorp USA Inc. purchased a new stake in Evolv Technologies in the 3rd quarter worth approximately $93,000. Caxton Associates LLP acquired a new stake in shares of Evolv Technologies during the 3rd quarter worth approximately $964,000. Worth Venture Partners LLC purchased a new position in shares of Evolv Technologies during the 3rd quarter valued at approximately $113,000. Finally, Dark Forest Capital Management LP lifted its stake in shares of Evolv Technologies by 27.9% in the 3rd quarter. Dark Forest Capital Management LP now owns 24,218 shares of the company’s stock valued at $183,000 after purchasing an additional 5,283 shares during the period. Hedge funds and other institutional investors own 66.65% of the company’s stock.

About Evolv Technologies

Evolv Technologies, Inc is a publicly traded American security technology company that develops and markets AI-driven weapons detection and screening solutions. The company’s proprietary platform combines advanced sensors, computer vision software and machine learning algorithms to identify potential threats—such as firearms and knives—while minimizing false positives and preserving high throughput. Evolv’s systems are designed to replace or supplement traditional metal detectors and manual bag checks in high-traffic venues.

The company’s flagship product, Evolv Express, integrates seamlessly into existing security checkpoints, allowing guests to pass through without stopping or emptying their pockets.